Ohcanbohtosat - Jeremy D. Waight
- Čájehuvvo 1 - 8 / 8
-
1
Identification of a G-CSF-Granulocytic MDSC axis that promotes tumor progression Dahkki Scott I. Abrams, Jeremy D. Waight
Almmustuhtton 2012Artigo -
2
-
3
Cutting Edge: Epigenetic Regulation of <i>Foxp3</i> Defines a Stable Population of CD4+ Regulatory T Cells in Tumors from Mice and Humans Dahkki Jeremy D. Waight, Shinji Takai, Bo Marelli, Guozhong Qin, Kenneth W. Hance, Dong Zhang, Robert M. Tighe, Yan Lan, Kin-Ming Lo, Helen Sabzevari, Robert Hofmeister, Nicholas S. Wilson
Almmustuhtton 2014Artigo -
4
Myeloid-derived suppressor cell development is regulated by a STAT/IRF-8 axis Dahkki Jeremy D. Waight, Colleen S. Netherby, Mary L. Hensen, Austin Miller, Qiang Hu, Song Liu, Paul N. Bogner, Matthew R. Farren, Kelvin P. Lee, Kebin Liu, Scott I. Abrams
Almmustuhtton 2013Artigo -
5
Baseline tumor growth and immune control in laboratory mice are significantly influenced by subthermoneutral housing temperature Dahkki Kathleen M. Kokolus, Maegan L. Capitano, Chen-Ting Lee, Jason W.‐L. Eng, Jeremy D. Waight, Bonnie L. Hylander, Sandra Sexton, Chi‐Chen Hong, Christopher J. Gordon, Scott I. Abrams, Elizabeth A. Repasky
Almmustuhtton 2013Artigo -
6
Selective FcγR Co-engagement on APCs Modulates the Activity of Therapeutic Antibodies Targeting T Cell Antigens Dahkki Jeremy D. Waight, Dhan Chand, Sylvia Dietrich, Randi B. Gombos, Thomas Horn, Ana María González, Mariana Manrique, Lukasz Swiech, Benjamin Morin, Christine Brittsan, Antoine Tanne, Belinda Akpeng, Ben A. Croker, Jennifer S. Buell, Robert B. Stein, David A. Savitsky, Nicholas S. Wilson
Almmustuhtton 2018Artigo -
7
TIGIT can inhibit T cell activation via ligation-induced nanoclusters, independent of CD226 co-stimulation Dahkki Jonathan D. Worboys, Katherine N. Vowell, Roseanna Hare, Ashley Ambrose, Margherita Bertuzzi, Michael A. Conner, Florence P. Patel, William H. Zammit, Judit Gali-Moya, Khodor S. Hazime, Katherine L. Jones, Camille Rey, Stipan Jonjić, T. Rovis, Gillian M. Tannahill, Gabriela Dos Santos Cruz De Matos, Jeremy D. Waight, Daniel M. Davis
Almmustuhtton 2023Artigo -
8
Botensilimab, an Fc-Enhanced Anti–CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy Dahkki Dhan Chand, David A. Savitsky, Shanmugarajan Krishnan, Gabriel Mednick, Chloé Delépine, Pilar García‐Broncano, Kah Teong Soh, Wei Wu, Margaret K. Wilkens, Olga Udartseva, Sylvia Vincent, Bishnu Joshi, Justin G. Keith, Mariana Manrique, Marilyn Marques, Antoine Tanne, Daniel L. Levey, Haiyong Han, Serina Ng, Jackson Ridpath, Olivia Huber, Benjamin Morin, C Galand, Sean Bourdelais, Randi B. Gombos, Rebecca Ward, Yu Qin, Jeremy D. Waight, Matthew R. Costa, Alvaro Sebastian-Yague, Nils-Petter Rudqvist, Malgorzata Pupecka-Swider, Vignesh Venkatraman, Andrew Slee, Jaymin Patel, Joseph E. Grossman, Nicholas S. Wilson, Daniel D. Von Hoff, Justin Stebbing, Tyler J. Curiel, Jennifer S. Buell, Steven O’Day, Robert B. Stein
Almmustuhtton 2024Artigo
Ohcanreaiddut:
Laktáseaddji fáttát
Immunology
Biology
Cancer research
Immune system
Medicine
T cell
Antibody
Cancer
Cell biology
Chemistry
Internal medicine
Myeloid
Myeloid-derived Suppressor Cell
Suppressor
Antigen
Biochemistry
CD8
Cancer immunotherapy
Effector
Gene
Genetics
Immunotherapy
Receptor
TIGIT
Acquired immune system
Antigen-presenting cell
Autoimmune disease
Botany
CTLA-4
Downregulation and upregulation